Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rocuronium bolus versus continuous infusion during thoracolaparoscopic esophagectomy
2014-002147-18Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rocuronium and Sugammadex in esophageal cancer (2 arms), sponsored by Academic Medical Center. Primary endpoint: Rating of surgical conditions during abdominal phase. Started Jan 2015; status: completed.
02
Drugs
rocuroniumSugammadex
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on 2014-002147-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002147-18.